Skip to main navigation Skip to search Skip to main content

Parkinson’s disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sample

  • Yuval Kozlov
  • , Noa Geffen
  • , Shiri Shulman
  • , Alon Zahavi
  • , Orly Gal-Or
  • , Assaf Dotan
  • , Sivan Gazit
  • , Tal Patalon
  • , Amit Meshi

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose: To evaluate the association between glaucoma and Parkinson’s disease (PD) over an extended follow-up period and to ascertain whether the diagnosis of glaucoma increases the risk for PD development. Methods: The anonymized electronic medical records of Israel’s second largest healthcare provider were retrospectively searched for all newly diagnosed patients with glaucoma aged 40 years or older from 2000 to 2021. A total of 139,554 patients were enrolled in this study, comprising 23,259 glaucoma patients and 116,295 sex- and age-matched controls. The incidence of PD was compared between groups. The main outcome measures were the incidence rates of PD and corresponding hazard ratio (HR) for PD development among the glaucoma cohort in relation to controls. Additionally, we aimed to evaluate the impact of various confounders, comorbidities, and demographic factors on the risk of PD development in the glaucoma population. Results: Glaucoma was not significantly associated with an increased risk of PD, with an adjusted HR of 1.145 (95% CI = 0.975–1.345). Age, male sex, and diabetes mellitus demonstrated a significant positive association with PD development in a univariate and multivariate analyses. Furthermore, the cumulative hazard log-rank test was not statistically significant (p = 0.055), suggesting no clear association between glaucoma and PD risk over the follow-up period. Conclusion: This large-scale study found no statistically significant association between glaucoma and the risk of developing PD. These findings suggest that any potential relationship is likely weak and may be influenced by confounding factors.

Original languageEnglish
Pages (from-to)3471-3481
Number of pages11
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume263
Issue number12
DOIs
StatePublished - 1 Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Glaucoma
  • Neurodegenerative disorders
  • Parkinson's disease

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Parkinson’s disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sample'. Together they form a unique fingerprint.

Cite this